Shvetank Bhatt

2.2k total citations · 1 hit paper
58 papers, 1.4k citations indexed

About

Shvetank Bhatt is a scholar working on Molecular Biology, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Shvetank Bhatt has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Biological Psychiatry and 12 papers in Pharmacology. Recurrent topics in Shvetank Bhatt's work include Tryptophan and brain disorders (16 papers), Stress Responses and Cortisol (10 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Shvetank Bhatt is often cited by papers focused on Tryptophan and brain disorders (16 papers), Stress Responses and Cortisol (10 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Shvetank Bhatt collaborates with scholars based in India, Malaysia and Australia. Shvetank Bhatt's co-authors include Chandragouda R. Patil, Anantha Naik Nagappa, Thangaraj Devadoss, Radhakrishnan Mahesh, Lakshman Puli, Ankur Jindal, Dinesh Kumar Chellappan, Gaurav Gupta, Neeraj Mishra and Kamal Dua and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Environmental Science and Pollution Research.

In The Last Decade

Shvetank Bhatt

57 papers receiving 1.4k citations

Hit Papers

Role of oxidative stress in depression 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of oxidative stress in depression
    2020 530 citations Shvetank Bhatt, Anantha Naik Nagappa et al. Drug Discovery Today profile →

Peers

Shvetank Bhatt
Mariola Herbet Poland
Paolo Tucci Italy
Alexandre Giusti‐Paiva Brazil
Emre Sarandöl Türkiye
Shayan Amiri Iran
Margherita Zotti Italy
Shanshan Li China
Antonia Patruno Italy
Ning Jiang China
Mariola Herbet Poland
Shvetank Bhatt
Citations per year, relative to Shvetank Bhatt Shvetank Bhatt (= 1×) peers Mariola Herbet

Countries citing papers authored by Shvetank Bhatt

Since Specialization
Citations

This map shows the geographic impact of Shvetank Bhatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shvetank Bhatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shvetank Bhatt more than expected).

Fields of papers citing papers by Shvetank Bhatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shvetank Bhatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shvetank Bhatt. The network helps show where Shvetank Bhatt may publish in the future.

Co-authorship network of co-authors of Shvetank Bhatt

This figure shows the co-authorship network connecting the top 25 collaborators of Shvetank Bhatt. A scholar is included among the top collaborators of Shvetank Bhatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shvetank Bhatt. Shvetank Bhatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anitha, Kuttiappan, et al.. (2025). Current drug targets for the treatment of depression. SHILAP Revista de lepidopterología. 19. 100270–100270.
2.
Mishra, Neeraj, Ashish Garg, Sumel Ashique, & Shvetank Bhatt. (2024). Potential of postbiotics for the treatment of metabolic disorders. Drug Discovery Today. 29(4). 103921–103921. 19 indexed citations
3.
Bhatt, Shvetank, Kuttiappan Anitha, Dinesh Kumar Chellappan, et al.. (2023). Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach. Metabolic Brain Disease. 39(2). 335–346. 7 indexed citations
4.
Kumar, Sachin, et al.. (2023). Active constituents of herbal medicines for breast cancer: Current status. Journal of Applied Pharmaceutical Science. 2 indexed citations
5.
Shilpi, Satish, Shvetank Bhatt, Pawan Kumar Gupta, et al.. (2023). Nanosizing Approaches: Current Trends in the Solubility Enhancement of Poorly Water-soluble Drugs. Indian Journal of Pharmaceutical Education and Research. 57(3). 625–639. 1 indexed citations
6.
Bhatt, Shvetank, Thangaraj Devadoss, Niraj Kumar Jha, et al.. (2022). Targeting inflammation: a potential approach for the treatment of depression. Metabolic Brain Disease. 38(1). 45–59. 51 indexed citations
7.
Alharbi, Khalid Saad, Yogendra Singh, Waleed Hassan Almalki, et al.. (2022). Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora. Chemico-Biological Interactions. 358. 109898–109898. 24 indexed citations
8.
Bhatt, Shvetank, Tapan Behl, Aayush Sehgal, et al.. (2022). Investigation of Cochlospermum religiosum leaves for antidepressant and anxiolytic activities and its synergistic effect with imipramine and fluoxetine. Environmental Science and Pollution Research. 29(18). 27172–27181. 1 indexed citations
9.
Ashique, Sumel, Gabriele De Rubis, Neeraj Mishra, et al.. (2022). Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chemico-Biological Interactions. 368. 110231–110231. 73 indexed citations
10.
Ashique, Sumel, Ashish Garg, Neeraj Kumar Mishra, et al.. (2022). Impact of ecDNA: A mechanism that directs tumorigenesis in cancer drug Resistance-A review. Chemico-Biological Interactions. 363. 110000–110000. 9 indexed citations
11.
Bhatt, Shvetank, et al.. (2021). Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine. SHILAP Revista de lepidopterología. 2. 100021–100021. 7 indexed citations
12.
Bhatt, Shvetank, et al.. (2020). Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression. Current Drug Targets. 22(2). 183–191. 17 indexed citations
13.
Bhatt, Shvetank, Lakshman Puli, & Chandragouda R. Patil. (2020). Role of reactive oxygen species in the progression of Alzheimer’s disease. Drug Discovery Today. 26(3). 794–803. 130 indexed citations
14.
Bhatt, Shvetank, Anantha Naik Nagappa, & Chandragouda R. Patil. (2020). Role of oxidative stress in depression. Drug Discovery Today. 25(7). 1270–1276. 530 indexed citations breakdown →
15.
Bhatt, Shvetank, Radhakrishnan Mahesh, Ankur Jindal, & Thangaraj Devadoss. (2016). Neuropharmacological and neurochemical evaluation of N - n - propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT 3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats. Journal of Basic and Clinical Physiology and Pharmacology. 28(2). 93–100. 8 indexed citations
16.
Bhatt, Shvetank, Radhakrishnan Mahesh, Thangaraj Devadoss, & Ankur Jindal. (2016). Neuropharmacological evaluation of a novel 5-HT 3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice. Journal of Basic and Clinical Physiology and Pharmacology. 28(2). 101–106. 15 indexed citations
17.
18.
Bhatt, Shvetank, et al.. (2013). Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety. Indian Journal of Pharmacology. 45(3). 248–248. 7 indexed citations
19.
20.
Mahesh, Radhakrishnan, et al.. (2010). Design, synthesis and structure–activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression. Bioorganic & Medicinal Chemistry Letters. 20(22). 6773–6776. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariola Herbet Breakdown of academic impact, for papers by Paolo Tucci Breakdown of academic impact, for papers by Alexandre Giusti‐Paiva Breakdown of academic impact, for papers by Emre Sarandöl Breakdown of academic impact, for papers by Shayan Amiri Breakdown of academic impact, for papers by Margherita Zotti Breakdown of academic impact, for papers by Shanshan Li Breakdown of academic impact, for papers by Antonia Patruno Breakdown of academic impact, for papers by Ning Jiang
Rankless by CCL
2026